Wegovy, Ozempic, Zepbound, Mounjaro, and Trulicity are registered trademarks of Novo Nordisk and Eli Lilly
For some patients: For others: The future role of Retatrutide will become clearer as longer-term data continues to emerge
declares having received research grants from Boehringer Ingelheim, Merck, Mylan Pharmaceuticals, Novo Nordisk, Pfizer and Sanofi US Services
Knowing your peptide-pathway genetic profile can enrich conversations with your provider about whether liraglutide aligns with your biology, whether dosing adjustments might optimize results, or whether an alternative GLP-1 agent (semaglutide, tirzepatide) better suits your genetic predispositions
West, R
NIDDK Food Portions [7] National Institute of Diabetes and Digestive and Kidney Diseases